Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
J. Clin. Invest. Marta Guix, et al. 118:2609
doi:10.1172/JCI34588 [Go to this article.]

Problems with a PDF?